Bioactive peptides: Signaling the future

Journal of Cosmetic Dermatology

Volumn 8, Issue 1, 2009, Pages 8-13

  Fields, K ^a   Falla, T J ^b   Rodan, K ^a   Bush, L ^a  

^a Helix Biomedix Inc ^*  (United States)

^b Helix Biomedix Inc   (United States)

Author keywords

Acne; Active ingredient; Anti inflammatory and wound healing; Antiaging; Bioactive peptides

Indexed keywords

ACETYL HEXAPEPTIDE 3; ALPHA INTERMEDIN DERIVATIVE; ARGIRELINE; BOTULINUM TOXIN; BOTULINUM TOXIN A; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CECROPIN B; COLLAGEN TYPE 1; COMBIKINES; COSMETIC; INTERLEUKIN 6; OLIGOPEPTIDE; OLIGOPEPTIDE 10; PALMITOYL OLIGOPEPTIDE; PALMITOYL PENTAPEPTIDE 3; PALMITOYL TETRAPEPTIDE 7; PEPTIDE; PRASTERONE; PROTEINASE ACTIVATED RECEPTOR 2; REPLIKINES; RIGIN; SCLEROPROTEIN; SNY AKE; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG; WAGLERIN 1;

ACNE; AGING; AMINO ACID SEQUENCE; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; COLLAGEN DEGRADATION; CYTOKINE RELEASE; DOWN REGULATION; DRUG ACTIVITY; DRUG EFFICACY; DRUG SAFETY; EPITHELIZATION; IMMUNE RESPONSE; INNATE IMMUNITY; NEUROSECRETION; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; SKIN CARE; SKIN INJURY; SKIN PIGMENTATION; ULTRAVIOLET RADIATION; VASCULARIZATION; WOUND HEALING; WRINKLE; ACNE VULGARIS; BIOAVAILABILITY; CHEMICAL STRUCTURE; CHEMISTRY; CUTANEOUS PARAMETERS; DRUG EFFECT; DRUG TOXICITY; FEMALE; FORECASTING; HUMAN; MALE; METHODOLOGY; SKIN DISEASE; STRUCTURE ACTIVITY RELATION;

ACNE VULGARIS; BIOLOGICAL AVAILABILITY; DRUG TOXICITY; FACIAL DERMATOSES; FEMALE; FORECASTING; HUMANS; MALE; MOLECULAR STRUCTURE; PEPTIDES; SKIN AGING; SKIN CARE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 67049169380     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2009.00416.x     Document Type: Review

References (31)

1. Woodley DT, O'Keefe EJ, Prunieras M. Cutaneous wound healing: A model for cell-matrix interactions. J Am Acad Dermatol 1985; 12: 420-33.
2. Aycock RS, Raghow R, Stricklin GP, Seyer JM, Kang AH. Post-transcriptional inhibition of collagen and fibronectin synthesis by a synthetic homolog of a portion of the carboxyl-terminal propeptide of human type I collagen. J Biol Chem 1986; 261: 14355-60.
3. Katayama K, Armendariz-Borunda J, Raghow R, Kang AH, Seyer JM. A pentapeptide from type I procollagen promotes extracellular matrix production. J Biol Chem 1993; 268: 9941-4.
4. Katayama K, Seyer JM, Raghow R, Kang AH. Regulation of extracellular matrix production by chemically synthesized subfragments of type I collagen carboxy propeptide. Biochemistry 1991; 30: 7097-104.
5. Robinet A, Fahem A, Cauchard JH et al. Elastin-derived peptides enhance angiogenesis by promoting endothelial cell migration and tubulogenesis through upregulation of MT1-MMP. J Cell Sci 2005; 118: 343-56.
6. Harris SM, Falla TJ, Zhang L. Peptide fragments for inducing synthesis of extracellular matrix proteins. US Patent Appl 2007; 20,070,299,015.
7. Shaykhiev R, Beisswenger C, Kandler K et al. Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure. Am J Physiol Lung Cell Mol Physiol 2005; 289: L842-8.
8. Braff MH, Hawkins MA, Di Nardo A et al. Structure- function relationships among human cathelicidin peptides: Dissociation of antimicrobial properties from host immunostimulatory activities. J Immunol 2005; 174: 4271-8.
9. Lee PH, Rudisill JA, Lin KH et al. HB-107, a nonbacteriostatic fragment of the antimicrobial peptide cecropin B, accelerates murine wound repair. Wound Repair Regen 2004; 12: 351-8.
10. Pillai S, Oresajo C, Hayward J. Ultraviolet radiation and skin aging. roles of reactive oxygen species, inflammation and protease activation, and strategies for prevention of inflammation-induced matrix degradation - a review. Int J Cosmet Sci 2005; 27: 17-34.
11. Allolio B, Arlt W. DHEA treatment: Myth or reality? Trends Endocrinol Metab 2002; 13: 288-94.
12. Rocchi R, Biondi L, Cavaggion F et al. Synthesis and biological activity of tuftsin and rigin derivatives containing monosaccharides or monosaccharide derivatives. Int J Pept Protein Res 1987; 29: 262-75.
13. Apland JP, Biser JA, Adler M et al. Peptides that mimic the carboxy-terminal domain of SNAP-25 block acetylcholine release at an Aplysia synapse. J Appl Toxicol 1999; 19 (Suppl. 1): S23-6.
14. Blanes-Mira C, Clemente J, Jodas G et al. A synthetic hexapeptide (Argireline) with antiwrinkle activity. Int J Cosmet Sci 2002; 24: 303-10.
15. Sellin LC, Mattila K, Annila A et al. Conformational analysis of a toxic peptide from Trimeresurus wagleri which blocks the nicotinic acetylcholine receptor. Biophys J 1996; 70: 3-13.
16. Mookherjee N, Brown KL, Bowdish DM et al. Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J Immunol 2006; 176: 2455-64.
17. McInturff JE, Wang SJ, Machleidt T et al. Granulysin-derived peptides demonstrate antimicrobial and anti-inflammatory effects against Propionibacterium acnes. J Invest Dermatol 2005; 125: 256-63.
18. Howell MD. The role of human beta defensins and cathelicidins in atopic dermatitis. Curr Opin Allergy Clin Immunol 2007; 7: 413-7.
19. Schauber J, Gallo RL. Antimicrobial peptides and the skin immune defense system. J Allergy Clin Immunol 2009, April 24.
20. Yamasaki K, Di Nardo A, Bardan A et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med 2007; 13: 975-80.
21. Schaffer JV, Bolognia JL. The melanocortin-1 receptor: Red hair and beyond. Arch Dermatol 2001; 137: 1477-88.
22. Abdel-Malek ZA, Kadekaro AL, Kavanagh RJ et al. Melanoma prevention strategy based on using tetrapeptide alpha-MSH analogs that protect human melanocytes from UV-induced DNA damage and cytotoxicity. Faseb J 2006; 20: 1561-3.
23. Seiberg M, Paine C, Sharlow E et al. Inhibition of melanosome transfer results in skin lightening. J Invest Dermatol 2000; 115: 162-7.
24. Suzuki I, Tada A, Ollmann MM et al. Agouti signaling protein inhibits melanogenesis and the response of human melanocytes to alpha-melanotropin. J Invest Dermatol 1997; 108: 838-42.
25. Kim H, Choi J, Cho JK, Kim SY, Lee YS. Solid-phase synthesis of kojic acid-tripeptides and their tyrosinase inhibitory activity, storage stability, and toxicity. Bioorg Med Chem Lett 2004; 14: 2843-6.
26. Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol 2000; 9: 165-9.
27. Mitragotri S. Modeling skin permeability to hydrophilic and hydrophobic solutes based on four permeation pathways. J Control Release 2003; 86: 69-92.
28. Partidos CD, Beignon AS, Brown F, Kramer E, Briand JP, Muller S. Applying peptide antigens onto bare skin. induction of humoral and cellular immune responses and potential for vaccination. J Control Release 2002; 85: 27-34.
29. Lopes LB, Brophy CM, Furnish E et al. Comparative study of the skin penetration of protein transduction domains and a conjugated peptide. Pharm Res 2005; 22: 750-7.
30. Lopes LB, Collett JH, Bentley MV. Topical delivery of cyclosporin A: An in vitro study using monoolein as a penetration enhancer. Eur J Pharm Biopharm 2005; 60: 25-30.
31. Ham SW, Kang MJ, Park YM et al. Transdermal penetration of synthetic peptides and their penetration enhancement caused by some terpene compounds. Bull Korean Chem Soc 2007; 28: 1535-8.